Лебединец Андрей Александрович
26 works · 226 citations · h-index 3
Top works
- LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study
- Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
- Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study
- Efficacy and safety of lenvatinib and pembrolizumab in the treatment of endometrial cancer: data from routine clinical practice in Russia
- Interim results from a real-world ambispective study RAVE-Bladder: avelumab first-line maintenance therapy in patients with metastatic urothelial carcinoma
- Avelumab plus axitinib for first-line treatment of advanced renal cell carcinoma: A real-world ambispective RAVE-Renal study.
- Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
- Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study
- Current issues in clinical trials of radiopharmaceutical drugs (RPCD) at the present stage of nuclear medicine development
- The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice
- Avelumab in combination with axitinib and nivolumab in combination with ipilimumab in the first-line treatment of metastatic renal cell carcinoma: a realworld retrospective cohort study
- Avelumab and axitinib in metastatic renal cell carcinoma: Results from a real-world observational study RAVE-Renal
- Эффективность комбинации авелумаба и акситиниба в зависимости от степени распространения метастатического почечно-клеточного рака: подгрупповой анализ исследования RAVE-Renal
- Striktury uretry u bol'nykh rakom predstatel'noy zhelezy kak prichina inkontinentsii. Opyt lazernoy uretrotomii
- The long-term clinical efficacy and safety of lenvatinib plus pembrolizumab in endometrial cancer: data from routine clinical practice in Russia
- Perivascular epithelioid cell tumors: treatment characteristics. Clinical observation and literature review
- Эффективность и безопасность ленватиниба с пембролизумабом при распространенном почечноклеточном раке в реальной практике: обновленные данные российского наблюдательного исследования
- Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study
- The Leningrad Regional Clinical Hospital’s own experience of treating non-clear cell renal cell carcinoma with a combination of lenvatinib and pembrolizumab
- Efficacy of avelumab and axitinib depending on disease burden in patients with metastatic renal cell carcinoma: a subgroup analysis of the RAVE-Renal trial